• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舌鳞状细胞癌预后特征与免疫微环境的综合分析

An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma.

作者信息

Jin Yi, Wang Zhanwang, Tang Weizhi, Liao Muxing, Wu Xiangwei, Wang Hui

机构信息

Department of Radiation Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

Key Laboratory of Translational Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

出版信息

Front Oncol. 2022 Jul 13;12:891716. doi: 10.3389/fonc.2022.891716. eCollection 2022.

DOI:10.3389/fonc.2022.891716
PMID:35912229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9326056/
Abstract

Tongue squamous cell carcinoma (TSCC) is a prevalent cancer of the oral cavity. Survival metrics are usually unsatisfactory, even using combined treatment with surgery, radiation, and chemotherapy. Immune checkpoint inhibitors can prolong survival, especially in patients with recurrent or metastatic disease. However, there are few effective biomarkers to provide prognosis and guide immunotherapy. Here, we utilized weighted gene co-expression network analysis to identify the co-expression module and selected the turquoise module for further scrutiny. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses revealed the innate pathways. The findings indicated that cell junction organization, response to topologically incorrect protein, and regulation of cell adhesion pathways may be essential. Eleven crucial predictive genes (, , , , , , , , , , and ) were used to establish a risk model based on Cox and LASSO analyses of The Cancer Genome Atlas and GSE65858 databases (regarding overall survival). Kaplan-Meier analysis and receiver operating characteristic curve suggested that the risk model had better prognostic effectiveness than other clinical traits. Consensus clustering was used to classify TSCC samples into two groups with significantly different survival rates. ESTIMATE and CIBERSORT were used to display the immune landscape of TSCC and indicate the stromal score; specific types of immune cells, including naïve B cells, plasma cells, CD8 T cells, CD4 memory resting and memory activated T cells, follicular helper T cells, and T regulatory cells, may influence the heterogeneous immune microenvironment in TSCC. To further identify hub genes, we downloaded GEO datasets (GSE41613 and GSE31056) and successfully validated the risk model. Two hub genes ( and ) were strongly associated with CD4+ and CD8+ T cells and programmed cell death protein 1 (PD1) and PD-ligand 1.

摘要

舌鳞状细胞癌(TSCC)是口腔中一种常见的癌症。即使采用手术、放疗和化疗联合治疗,生存指标通常也不尽人意。免疫检查点抑制剂可以延长生存期,尤其是对于复发或转移性疾病患者。然而,很少有有效的生物标志物可用于提供预后信息和指导免疫治疗。在此,我们利用加权基因共表达网络分析来识别共表达模块,并选择绿松石模块进行进一步研究。基因本体论和京都基因与基因组百科全书分析揭示了固有途径。研究结果表明,细胞连接组织、对拓扑错误蛋白质的反应以及细胞粘附途径的调节可能至关重要。基于对癌症基因组图谱和GSE65858数据库(关于总生存期)的Cox和LASSO分析,使用11个关键预测基因(、、、、、、、、、和)建立了一个风险模型。Kaplan-Meier分析和受试者工作特征曲线表明,该风险模型比其他临床特征具有更好的预后效果。共识聚类用于将TSCC样本分为两组,其生存率有显著差异。使用ESTIMATE和CIBERSORT来展示TSCC的免疫格局并指示基质评分;特定类型的免疫细胞,包括幼稚B细胞、浆细胞、CD8 T细胞、CD4记忆静止和记忆激活T细胞、滤泡辅助性T细胞和调节性T细胞,可能会影响TSCC中异质性免疫微环境。为了进一步识别枢纽基因,我们下载了GEO数据集(GSE41613和GSE31056)并成功验证了该风险模型。两个枢纽基因(和)与CD4 +和CD8 + T细胞以及程序性细胞死亡蛋白1(PD1)和PD-配体1密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/0033937baa38/fonc-12-891716-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/37979024f898/fonc-12-891716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/7cadfaf6e7d0/fonc-12-891716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/6518dfa123aa/fonc-12-891716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/ba306f1e7719/fonc-12-891716-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/458adec9da4a/fonc-12-891716-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/990b1c4e9ec7/fonc-12-891716-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/43e176b8dcc4/fonc-12-891716-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/0033937baa38/fonc-12-891716-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/37979024f898/fonc-12-891716-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/7cadfaf6e7d0/fonc-12-891716-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/6518dfa123aa/fonc-12-891716-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/ba306f1e7719/fonc-12-891716-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/458adec9da4a/fonc-12-891716-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/990b1c4e9ec7/fonc-12-891716-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/43e176b8dcc4/fonc-12-891716-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40d0/9326056/0033937baa38/fonc-12-891716-g008.jpg

相似文献

1
An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma.舌鳞状细胞癌预后特征与免疫微环境的综合分析
Front Oncol. 2022 Jul 13;12:891716. doi: 10.3389/fonc.2022.891716. eCollection 2022.
2
Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma.基于 ssGSEA 的免疫相关预后特征新型亚型鉴定用于舌鳞癌。
Cancer Med. 2021 Dec;10(23):8693-8707. doi: 10.1002/cam4.4341. Epub 2021 Oct 20.
3
Identification of a novel immune gene panel in tongue squamous cell carcinoma.舌鳞状细胞癌中一种新型免疫基因panel的鉴定
Am J Transl Res. 2022 May 15;14(5):2801-2824. eCollection 2022.
4
Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.基于肝癌干细胞特征的预后标志物的免疫价值
Front Cell Dev Biol. 2021 Aug 2;9:710207. doi: 10.3389/fcell.2021.710207. eCollection 2021.
5
Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer.与侵袭性相关的特征基因鉴定及预测膀胱癌总生存期的预后模型构建
Front Genet. 2021 Sep 13;12:694777. doi: 10.3389/fgene.2021.694777. eCollection 2021.
6
Identification of co-expressed gene networks promoting CD8 T cell infiltration and having prognostic value in uveal melanoma.鉴定促进 CD8 T 细胞浸润并具有葡萄膜黑色素瘤预后价值的共表达基因网络。
BMC Ophthalmol. 2023 Aug 10;23(1):354. doi: 10.1186/s12886-023-03098-7.
7
The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.衰老相关预后特征揭示头颈部鳞状细胞癌肿瘤免疫微环境格局
Front Oncol. 2022 May 10;12:857994. doi: 10.3389/fonc.2022.857994. eCollection 2022.
8
Molecular Subtypes and CD4 Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer.与胃癌临床结局相关的分子亚型及基于CD4记忆性T细胞的特征
Front Oncol. 2021 Mar 17;10:626912. doi: 10.3389/fonc.2020.626912. eCollection 2020.
9
Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma.用于预测肺鳞状细胞癌总生存期的四基因铁死亡特征的鉴定与验证
Front Oncol. 2022 Jul 7;12:933925. doi: 10.3389/fonc.2022.933925. eCollection 2022.
10
Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.与食管鳞状细胞癌中M2巨噬细胞浸润相关的预后基因特征的开发与验证
Front Oncol. 2021 Dec 3;11:769727. doi: 10.3389/fonc.2021.769727. eCollection 2021.

引用本文的文献

1
N4BP3 Activates TLR4-NF-κB Pathway in Inflammatory Bowel Disease by Promoting K48-Linked IκBα Ubiquitination.N4BP3通过促进K48连接的IκBα泛素化激活炎症性肠病中的TLR4-NF-κB信号通路。
J Inflamm Res. 2025 Jun 3;18:7167-7181. doi: 10.2147/JIR.S518155. eCollection 2025.
2
Comprehensive analysis of INTS family related to expression, prognosis, diagnosis and immune features in hepatocellular carcinoma.肝细胞癌中与INTS家族的表达、预后、诊断及免疫特征相关的综合分析
Heliyon. 2024 Apr 24;10(9):e30244. doi: 10.1016/j.heliyon.2024.e30244. eCollection 2024 May 15.
3
An introduction to machine learning and generative artificial intelligence for otolaryngologists-head and neck surgeons: a narrative review.

本文引用的文献

1
Variation in Plasma Levels of TRAF2 Protein During Development of Squamous Cell Carcinoma of the Oral Tongue.舌鳞状细胞癌发生发展过程中TRAF2蛋白血浆水平的变化
Front Oncol. 2021 Nov 23;11:753699. doi: 10.3389/fonc.2021.753699. eCollection 2021.
2
Nivolumab vs Pembrolizumab for Treatment of US Patients With Platinum-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Network Meta-analysis and Cost-effectiveness Analysis.纳武利尤单抗对比帕博利珠单抗治疗铂类耐药复发性或转移性头颈部鳞状细胞癌的美国患者:一项网络荟萃分析和成本效益分析。
JAMA Netw Open. 2021 May 3;4(5):e218065. doi: 10.1001/jamanetworkopen.2021.8065.
3
耳鼻喉科-头颈外科医师的机器学习和生成式人工智能入门:叙述性综述。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2723-2731. doi: 10.1007/s00405-024-08512-4. Epub 2024 Feb 23.
4
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer.TFRC 与缺氧和免疫有关,是膀胱癌的预后因素和潜在治疗靶点。
Eur J Med Res. 2024 Feb 9;29(1):112. doi: 10.1186/s40001-024-01688-9.
5
[Expression of interleukin-34 in tongue squamous cell carcinoma and its clinical implications].[白细胞介素-34在舌鳞状细胞癌中的表达及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Dec 20;43(12):2111-2117. doi: 10.12122/j.issn.1673-4254.2023.12.16.
6
Identify and validate RUNX2 and LAMA2 as novel prognostic signatures and correlate with immune infiltrates in bladder cancer.鉴定并验证RUNX2和LAMA2作为膀胱癌新的预后标志物,并与免疫浸润相关联。
Front Oncol. 2023 Jul 13;13:1191398. doi: 10.3389/fonc.2023.1191398. eCollection 2023.
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
新辅助纳武利尤单抗或纳武利尤单抗联合伊匹单抗治疗未经治疗的口腔鳞状细胞癌:一项开放标签、随机 2 期临床试验。
JAMA Oncol. 2020 Oct 1;6(10):1563-1570. doi: 10.1001/jamaoncol.2020.2955.
4
Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA).通过大规模转录谱分析非小细胞肺癌亚型的分子特征:利用加权基因共表达网络分析(WGCNA)鉴定关键模块和基因
Cancers (Basel). 2019 Dec 21;12(1):37. doi: 10.3390/cancers12010037.
5
Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.T 滤泡辅助细胞的免疫特征可预测肺鳞状细胞癌的临床预后和治疗影响。
Int Immunopharmacol. 2020 Apr;81:105932. doi: 10.1016/j.intimp.2019.105932. Epub 2019 Dec 10.
6
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.帕博利珠单抗单药或联合化疗对比西妥昔单抗联合化疗用于治疗复发性或转移性头颈部鳞状细胞癌(KEYNOTE-048):一项随机、开放标签、III 期研究。
Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.
7
MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression.微小RNA-193a-3p通过下调PLAU表达抑制结肠癌细胞的增殖和进展。
Cancer Manag Res. 2019 Jun 12;11:5353-5363. doi: 10.2147/CMAR.S208233. eCollection 2019.
8
Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.通过综合生物信息学分析筛选和鉴定胰腺癌的枢纽基因。
J Cell Biochem. 2019 Dec;120(12):19496-19508. doi: 10.1002/jcb.29253. Epub 2019 Jul 11.
9
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.纳武利尤单抗治疗复发或转移性头颈部鳞状细胞癌患者:CheckMate 141 研究中既往接受西妥昔单抗治疗患者的疗效和安全性。
Clin Cancer Res. 2019 Sep 1;25(17):5221-5230. doi: 10.1158/1078-0432.CCR-18-3944. Epub 2019 Jun 25.
10
CD8 cytotoxic T lymphocytes in cancer immunotherapy: A review.癌症免疫治疗中的 CD8 细胞毒性 T 淋巴细胞:综述。
J Cell Physiol. 2019 Jun;234(6):8509-8521. doi: 10.1002/jcp.27782. Epub 2018 Nov 22.